Skip to main content
Log in

Plasminogen activator activity in differentiating rat myoblasts

  • Original Articles
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Summary

Primary cultures of skeletal muscle cells secrete plasminogen activator (PA) activity to the conditioning medium and display membrane-bound PA. Growth of these cells in culture in presence of 10-7 M dexamethasone resulted in a marked reduction of the membranal and secreted PA activity. The hormone also reduced cytosolic creative phosphokinase (CPK) activity and cytosolic protein content. However, cell viability and their ability to undergo fusion were uneffected. The extent of hormone-induced reduction in PA activity depended on the time and extend of exposure. Maximal suppression was obtained by exposing the cells to dexamethasone during the first 4 days of culture. The medium conditioned with dexamethasone-treated cells did not inhibit plasmin, endogenous PA or exogenous PA. Exposure of the conditioned medium from hormone-treated cells to sodium dodecyl sulphate (SDS) or trypsin restored the activity to values observed in media from cells not exposed to the hormone. Acidification of the medium failed to reactivate the enzyme. The myogenic cell line L-8 also displayed membrane-bound PA activity, which was of a comparable magnitude in both fusing and non-fusing L-8 cells. However, in contrast to the primary cultures, exposure of L-8 cells to dexamethasone had no effect on their PA activity whether studied under conditions which allowed or prohibited fusion. The present findings imply that PA has no conducive role in the process of fusion associated with maturation of skeletal muscle cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CPK:

Creative phosphokinase

PA:

Plasminogen activator

PBS:

Phosphate buffered saline

SDS:

Sodium dodecyl sulphate

TCA:

Trichloroacetic acid

References

  1. Yaffe D: Rat skeletal muscle cells. In: Kruse PF, Patterson MK (eds) Tissue Culture Methods and Applications. Academic Press, New York, pp 106–114, 1973.

    Google Scholar 

  2. Bischoff R, Holtzer H: Mitosis and the processes of differentiation of myogenic cells in vitro. J Cell Biol 44:188–201, 1969.

    Google Scholar 

  3. Dym H, Turner DC, Eppenberger HM, Yaffe D: Creatine kinase isoenzyme transition in actinomycin D-treated differentiating muscle cultures. Exp Cell Res 113:15–21, 1978.

    Google Scholar 

  4. Sanwal BD: Myoblast differentiation. Trends Biochem Sci 4:155–157, 1979.

    Google Scholar 

  5. Lavie G, Yaffe D: Studies on the nature of the last cell division during the differentiation of rat skeletal muscle cells. In: Muller-Berat N et al. (ed) Progress in Differentiation Research. North-Holland Publishing Company, Amsterdam, pp 25–42, 1976.

    Google Scholar 

  6. Couch CB, Strittmatter WJ: Rat myoblast fusion requires metalloendoprotease activity. Cell 32:257–265, 1983.

    Google Scholar 

  7. Kaur H, Sanwal BD: Regulation of the activity of a calcium-activated neutral protease during differentiation of skeletal myoblasts. Can J Biochem 59:743–747, 1981.

    Google Scholar 

  8. Kirschke H, Wood L, Roisen FJ, Bird JWC: Activity of lysosomal cysteine proteinase during differentiation of rat skeletal muscle. Biochem J 214:871–877, 1983.

    Google Scholar 

  9. Miskin R, Easton TG, Reich E: Plasminogen activator in chick embryo muscle cells: Induction of enzyme by RSV, PMA and retinoic acid. Cell 15:1301–1312, 1978.

    Google Scholar 

  10. Festoff BW, Patterson MR, Romstedt K: Plasminogen activator: The major secreted neutral protease of cultured skeletal muscle cells. J Cell Physiol 110:190–195, 1982.

    Google Scholar 

  11. Christmas JK, Silverstein SC, Acs G: Plasminogen activators. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. North Holland Publishing Company, Amsterdam, pp 91–149, 1977.

    Google Scholar 

  12. Ossowski L, Beigel D, Reich E: Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16:929–940, 1979.

    Google Scholar 

  13. Isseroff R, Fusenig NE, Rifkin DB: Plasminogen activator in differentiating mouse keratinocytes. J Invest Dermatol 80:217–222, 1983.

    Google Scholar 

  14. Guerriero V, Florini JR: Dexamethasone effects on myoblast proliferation and differentiation. Endocrinology 106:1198–1202, 1980.

    Google Scholar 

  15. Mayer M, Chaouat M, Hadar R, Nissan S: Effect of dexamethasone and serum-deprivation on intracellular proteolysis in cultured muscle cells. J Cell Physiol 109:525–533, 1981.

    Google Scholar 

  16. Deutsch DG, Mertz ET: Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095–1096, 1970.

    Google Scholar 

  17. Scales D, Sabbadini R, Inesi G: The involvement of sarcotubular membranes in genetic muscular dystrophy. Biochem Biophys Acta 465:535–549, 1977.

    Google Scholar 

  18. Mayer M, Finci Z, Kanaany J, Kaiser N: Plasminogen activator and protease inhibitor activities in isolated rat thymocytes. Mol Cell Biochem 66:137–144, 1985.

    Google Scholar 

  19. Roth JS, Losty T, Wierbicki E: Assay of proteolytic enzyme activity using a 14C-labeled hemoglobin. Anal Biochem 42:214–221, 1971.

    Google Scholar 

  20. Mayer M, Neufeld B, Finci Z: Inhibition of serine proteases by steroids. Biochem Pharmacol 31:2989–2992, 1982.

    Google Scholar 

  21. Levin EG: Latent tissue plasminogen activator produced by human endothelial cells in culture: Evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA 80:6804–6808, 1983.

    Google Scholar 

  22. Lowry DH, Rosebrough WJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951.

    CAS  PubMed  Google Scholar 

  23. Schomberg M, Smith TJ, Krichevsky A, Bilezikian JP: Glucocorticoids enhance glucose uptake and affect differentiation and beta-adrenergic responsiveness in muscle cell cultures. Cell Differentiation 10:101–107, 1981.

    Google Scholar 

  24. Gelehrter TD, Barouski-Miller PA, Coleman PL, Cwikel BJ: Hormonal regulation of plasminogen activator in rat hepatoma cells. Molec Cell Biochem 53/54:11–21, 1983.

    Google Scholar 

  25. Crutchley DJ, Conanan LB, Maynard JR: Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids. Ann NY Acad Sci 370:609–616, 1981.

    Google Scholar 

  26. Laug WE: Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb Haemostas 50:888–892, 1983.

    Google Scholar 

  27. Coleman PL, Barouski PA, Gelehrter TD: The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation. J Biol Chem 257:4250–4264, 1982.

    Google Scholar 

  28. Granelli-Piperno A, Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 148:223–234, 1978.

    Google Scholar 

  29. Scott RW, Eaton DL, Duran N, Baker JB: Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin. J Biol Chem 258:4397–4403, 1983.

    Google Scholar 

  30. Klocking HP, Jablonowski CH, Markwardt F: Studies on the release on plasminogen activator from the isolated rat lung by serine proteinases. Thromb Res 23:375–379, 1982.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayer, M., Finci, Z., Chaouat, M. et al. Plasminogen activator activity in differentiating rat myoblasts. Mol Cell Biochem 69, 147–154 (1986). https://doi.org/10.1007/BF00224761

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00224761

Keywords

Navigation